UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model

American journal of respiratory cell and molecular biology, 2013-02, Vol.48 (2), p.220-229

2013

Volltextzugriff (PDF)

Ligand bias prevents class equality among beta-blockers

Current opinion in pharmacology, 2014-06, Vol.16, p.50-57

2014

Volltextzugriff (PDF)

A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA A Receptors in the Lung

Molecular pharmaceutics, 2018-05, Vol.15 (5), p.1766-1777

2018

Volltextzugriff (PDF)

A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung

Molecular pharmaceutics, 2018-05, Vol.15 (5), p.1766-1777

2018

Volltextzugriff (PDF)

Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout Mice

American journal of respiratory cell and molecular biology, 2016-08, Vol.55 (2), p.234-242

2016

Volltextzugriff (PDF)

Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABAA Receptor Modulators

Molecular pharmaceutics, 2017-06, Vol.14 (6), p.2088-2098

2017

Volltextzugriff (PDF)

Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory

Neuroscience letters, 2013-08, Vol.548, p.296-300

2013

Volltextzugriff (PDF)

Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABA A Receptor Modulators

Molecular pharmaceutics, 2017-06, Vol.14 (6), p.2088-2098

2017

Volltextzugriff (PDF)

Optimization of substituted imidazobenzodiazepines as novel asthma treatments

European journal of medicinal chemistry, 2017-01, Vol.126, p.550-560

2017

Volltextzugriff (PDF)

Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments

Molecular pharmaceutics, 2016-06, Vol.13 (6), p.2026-2038

2016

Volltextzugriff (PDF)

A New Pharmacological Approach for Asthma through Tissue-Specific Modulation of the GABA(A) Receptor

Journal of allergy and clinical immunology, 2016-02, Vol.137 (2), p.AB393-AB393

2016

Volltextzugriff (PDF)

Reply: Adverse effects of long-acting beta-agonists on airway hyperresponsiveness

American journal of respiratory cell and molecular biology, 2013-09, Vol.49 (3), p.502-502

2013

Volltextzugriff (PDF)

Chronic treatment with DCPCX, an adenosine A1 antagonist, worsens long-term memory

Neuroscience letters, 2013-08, Vol.548, p.296-300

2013

Volltextzugriff (PDF)

Development of GABA A Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments

Molecular pharmaceutics, 2016-06, Vol.13 (6), p.2026-2038

2016

Volltextzugriff (PDF)

Correction to “A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung”

Molecular pharmaceutics, 2019-11, Vol.16 (11), p.4756-4756

2019

Volltextzugriff (PDF)

Correction to “A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA A Receptors in the Lung”

Molecular pharmaceutics, 2019-11, Vol.16 (11), p.4756-4756

2019

Volltextzugriff (PDF)

Reducing airway constriction and inflammation through GABAA receptors in the lung with a novel, orally available drug candidate

The Journal of immunology (1950), 2018-05, Vol.200 (1_Supplement), p.44-44.11

2018

Volltextzugriff (PDF)

The role of the ß2‐adrenoceptor Gs pathway in the development of the asthma phenotype in murine models

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

Targeting the immune system with subtype-selective GABAA receptor modulator to alleviate asthma symptoms

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.192-192.16

2016

Volltextzugriff (PDF)

Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β 2 -Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase–Knockout Mice

American journal of respiratory cell and molecular biology, 2016-08, Vol.55 (2), p.234-242

2016

Volltextzugriff (PDF)

β 2 -Adrenoceptor Agonists Are Required for Development of the Asthma Phenotype in a Murine Model

American journal of respiratory cell and molecular biology, 2013-02, Vol.48 (2), p.220-229

2013

Volltextzugriff (PDF)

Clinical Drug Candidate MIDD0301 is a Novel Oral Asthma Treatment combating Inflammation and Muscle Constriction in the Lung

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB81-AB81

2018

Volltextzugriff (PDF)

α4‐selective GABA A Receptor Positive Allosteric Modulator Attenuates The “Asthma‐Like Phenotype” In A Murine Asthma Model

The FASEB journal, 2016-04, Vol.30 (S1)

2016

Volltextzugriff (PDF)

New Oral Treatments for Asthma through Tissue-Specific Modulation of the GABAA Receptor

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB9-AB9

2017

Volltextzugriff (PDF)

Role of biased signaling by beta‐blockers in the development of asthma phenotype in a murine model

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model

Ligand bias prevents class equality among beta-blockers

A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA A Receptors in the Lung

A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung

Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout Mice

Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABAA Receptor Modulators

Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory

Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABA A Receptor Modulators

Optimization of substituted imidazobenzodiazepines as novel asthma treatments

Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments

A New Pharmacological Approach for Asthma through Tissue-Specific Modulation of the GABA(A) Receptor

Reply: Adverse effects of long-acting beta-agonists on airway hyperresponsiveness

Chronic treatment with DCPCX, an adenosine A1 antagonist, worsens long-term memory

Development of GABA A Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments

Correction to “A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung”

Correction to “A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA A Receptors in the Lung”

Reducing airway constriction and inflammation through GABAA receptors in the lung with a novel, orally available drug candidate

The role of the ß2‐adrenoceptor Gs pathway in the development of the asthma phenotype in murine models

Targeting the immune system with subtype-selective GABAA receptor modulator to alleviate asthma symptoms

Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β 2 -Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase–Knockout Mice

β 2 -Adrenoceptor Agonists Are Required for Development of the Asthma Phenotype in a Murine Model

Clinical Drug Candidate MIDD0301 is a Novel Oral Asthma Treatment combating Inflammation and Muscle Constriction in the Lung

α4‐selective GABA A Receptor Positive Allosteric Modulator Attenuates The “Asthma‐Like Phenotype” In A Murine Asthma Model

New Oral Treatments for Asthma through Tissue-Specific Modulation of the GABAA Receptor

Role of biased signaling by beta‐blockers in the development of asthma phenotype in a murine model

Suchergebnisse filtern